Daniel H. Sterman

7.3k total citations · 1 hit paper
105 papers, 4.4k citations indexed

About

Daniel H. Sterman is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Genetics. According to data from OpenAlex, Daniel H. Sterman has authored 105 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 24 papers in Biotechnology and 23 papers in Genetics. Recurrent topics in Daniel H. Sterman's work include Occupational and environmental lung diseases (39 papers), Pleural and Pulmonary Diseases (33 papers) and Virus-based gene therapy research (22 papers). Daniel H. Sterman is often cited by papers focused on Occupational and environmental lung diseases (39 papers), Pleural and Pulmonary Diseases (33 papers) and Virus-based gene therapy research (22 papers). Daniel H. Sterman collaborates with scholars based in United States, Germany and Netherlands. Daniel H. Sterman's co-authors include Steven Μ. Albelda, Larry R. Kaiser, Ali I. Musani, Leslie A. Litzky, Andrew R. Haas, James M. Wilson, Kunjlata M. Amin, Katherine L. Molnar-Kimber, Joseph S. Friedberg and Stephen M. Hahn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Daniel H. Sterman

100 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

2018 260 citations Hedy L. Kindler, Nofisat Ismaila et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Daniel H. Sterman

Since Specialization

Citations

This map shows the geographic impact of Daniel H. Sterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Sterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Sterman more than expected).

Fields of papers citing papers by Daniel H. Sterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Sterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Sterman. The network helps show where Daniel H. Sterman may publish in the future.

Co-authorship network of co-authors of Daniel H. Sterman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Sterman. A scholar is included among the top collaborators of Daniel H. Sterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Sterman. Daniel H. Sterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential Effects of High-Fiber and Low-Fiber Diets on Antitumor Immunity and Colon Tumor Progression in a Murine Model 2025 ·Cancer Prevention Research ·(unknown), (unknown), Benjamin G. Wu, (unknown), Matthias C. Kugler, Miao Chang, (unknown), Yonghua Li, (unknown), (unknown), Jun-Chieh J. Tsay, (unknown), Daniel H. Sterman, Leopoldo N. Segal, Nejat K. Egilmez, (unknown)	2
2	A PROSPECTIVE, MULTICENTER EVALUATION OF SAFETY AND DIAGNOSTIC OUTCOMES WITH ROBOTIC-ASSISTED BRONCHOSCOPY: RESULTS FROM THE TARGET TRIAL 2024 ·CHEST Journal ·(unknown), Daniel H. Sterman, (unknown), Kazuhiro Yasufuku, (unknown), Samaan Rafeq, (unknown), Michael Schwiers, (unknown)	2
3	Overall survival after treatment with CAN-2409 plus valacyclovir in combination with continued ICI in patients with stage III/IV NSCLC with an inadequate response to ICI. 2024 ·Journal of Clinical Oncology ·Charu Aggarwal, Daniel H. Sterman, Erin R. Alesi, Fabien Maldonado, Ranee Mehra, Christine M. Bestvina, Janani Reisenauer, (unknown), Sonam Puri, Omar M. Ibrahim, George A. Eapen, Caroline Duault, (unknown), Diane M. Del Valle, Edgar Gonzalez‐Kozlova, Sacha Gnjatic, Holden T. Maecker, (unknown), Francesca Barone, Paul P. Tak	6
4	Low-field MRI lung opacity severity associated with decreased DLCO in post-acute Covid-19 patients 2024 ·Clinical Imaging ·Lea Azour, Leopoldo N. Segal, Rany Condos, (unknown), Nicholas Landini, (unknown), Daniel H. Sterman, (unknown), Jane P. Ko, Shari B. Brosnahan, James S. Babb, Hersh Chandarana	0
5	Mesothelioma Cases in the World Trade Center Survivors 2024 ·PubMed ·(unknown), (unknown), Katherine S. Pollard, Nedim Durmuş, (unknown), Daniel H. Sterman, Alan A. Arslan, Yongzhao Shao, Joan Reibman	0
6	Value of metalloproteinases in predicting COPD in heavy urban smokers 2020 ·Respiratory Research ·Jun-Chieh J. Tsay, Yingjie Hu, Judith D. Goldberg, Bin Wang, (unknown), Ting-An Yie, (unknown), Daniel H. Sterman, William N. Rom	7
7	CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma 2020 ·Lung Cancer ·Ian Berger, Scott Simpson, (unknown), Melissa Culligan, E. Paul Wileyto, Evan Alley, Daniel H. Sterman, AM Patel, (unknown), (unknown), Keith A. Cengel, Sharyn I. Katz, Leonid Roshkovan	1
8	Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline breakdown → 2018 ·Journal of Clinical Oncology ·Hedy L. Kindler, Nofisat Ismaila, Samuel G. Armato, Raphael Bueno, Mary Hesdorffer, Thierry Jahan, Clyde Jones, Markku Miettinen, Harvey I. Pass, Andreas Rimner, Valerie W. Rusch, Daniel H. Sterman, Anish Thomas, Raffit Hassan	260
9	The Immune Landscape of Non–Small-Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures 2018 ·American Journal of Respiratory and Critical Care Medicine ·Jason Beattie, Lonny Yarmus, Momen M. Wahidi, M. Patricia Rivera, Christopher R. Gilbert, Fabien Maldonado, (unknown), A. Christine Argento, Alexander Chen, Felix Herth, Daniel H. Sterman	14
10	Updates in the diagnosis and treatment of malignant pleural mesothelioma 2018 ·Current Opinion in Pulmonary Medicine ·(unknown), Daniel H. Sterman	18
11	Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline 2017 ·Journal of Clinical Oncology ·Bryan J. Schneider, Megan E. Daly, Erin B. Kennedy, Mara B. Antonoff, Stephen Broderick, Jill Feldman, Shruti Jolly, Bryan F. Meyers, Gaetano Rocco, Chad G. Rusthoven, Ben J. Slotman, Daniel H. Sterman, Brendon M. Stiles	111
12	Checkpoint Blockade in Lung Cancer and Mesothelioma 2017 ·American Journal of Respiratory and Critical Care Medicine ·Lysanne A. Lievense, Daniel H. Sterman, Robin Cornelissen, Joachim G.J.V. Aerts	54
13	Transbronchial Cryobiopsies: Evidence Moving at Glacial Speed? 2015 ·CHEST Journal ·J.L. Bessich, Laura Frye, Edmund K. Moon, Anthony R. Lanfranco, Andrew R. Haas, Anil Vachani, Daniel H. Sterman	1
14	Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules 2015 ·Thorax ·Felix Herth, Robert T. Eberhardt, Daniel H. Sterman, Gerard A. Silvestri, (unknown), Pallav L. Shah	87
15	A Trial of Intrapleural Adenoviral-mediated Interferon-α2b Gene Transfer for Malignant Pleural Mesothelioma 2011 ·American Journal of Respiratory and Critical Care Medicine ·Daniel H. Sterman, Andrew R. Haas, Edmund K. Moon, (unknown), (unknown), Anil Vachani, Sharyn I. Katz, Colin T. Gillespie, Guanjun Cheng, Jing Sun, Emmanouil Papasavvas, Luis J. Montaner, Daniel F. Heitjan, Leslie A. Litzky, Joseph S. Friedberg, Melissa Culligan, Carl H. June, Richard G. Carroll, Steven Μ. Albelda	72
16	Advances in Diagnostic Bronchoscopy 2010 ·American Journal of Respiratory and Critical Care Medicine ·Andrew R. Haas, Anil Vachani, Daniel H. Sterman	48
17	Endobronchial Valve Treatment for Prolonged Air Leaks of the Lung: A Case Series 2010 ·The Annals of Thoracic Surgery ·Colin T. Gillespie, Daniel H. Sterman, Robert J. Cerfolio, (unknown), Michael S. Mulligan, Richard A. Mularski, Ali I. Musani, John C. Kucharczuk, (unknown), Steven C. Springmeyer	80
18	Bronchial sleeve resection for posttransplant stricture 2003 ·The Annals of Thoracic Surgery ·Emily Carter Paulson, Sunil Singhal, John C. Kucharczuk, Daniel H. Sterman, Larry R. Kaiser, M. Blair Marshall	9
19	Advances in the Treatment of Malignant Pleural Mesothelioma 1999 ·CHEST Journal ·Daniel H. Sterman, Larry R. Kaiser, Steven Μ. Albelda	105
20	Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. 1997 ·PubMed ·John C. Kucharczuk, B. Randazzo, Michael Y. Chang, K M Amin, Ashraf A. Elshami, Daniel H. Sterman, Nabil P. Rizk, Katherine L. Molnar-Kimber, Stuart M. Brown, Alasdair Maclean, Leslie A. Litzky, Nicholas Fraser, Steven Μ. Albelda, Larry R. Kaiser	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact